Phase 2 UTI Clinical Trials
59 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 59 trials
Recruiting
Phase 2Phase 3
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial
Autism Spectrum Disorder
Stanford University144 enrolled1 locationNCT05664789
Recruiting
Phase 2
Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose
Autism Spectrum Disorder
Stanford University24 enrolled1 locationNCT04278898
Recruiting
Phase 2
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies
Cervical CancerEndometrial CancerVaginal Cancer+4 more
University of Utah70 enrolled1 locationNCT05979610
Recruiting
Phase 2
Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism
Autism Spectrum DisorderLanguage Disorders
Southwest Autism Research & Resource Center80 enrolled2 locationsNCT04060030
Recruiting
Phase 2
A Digital Intervention for Post-Stroke Depression and Executive Dysfunction
DepressionStrokeExecutive Dysfunction
Weill Medical College of Cornell University70 enrolled1 locationNCT05507138
Recruiting
Phase 2
TB006 for Autism Spectrum Disorder
Autism Spectrum Disorder
Rossignol Medical Center45 enrolled2 locationsNCT06500637
Recruiting
Phase 1Phase 2
Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism
Autism Spectrum Disorder (ASD)Prospective Study
Dongfang People's Hospital40 enrolled1 locationNCT07243561
Recruiting
Phase 2
A Phase 2A Trial of DT402 for Autism Spectrum Disorder
Autism Spectrum DisorderASD
Definium Therapeutics US, Inc.20 enrolled1 locationNCT07303907
Recruiting
Phase 2
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
ParonychiaAcneiform Eruption Due to ChemicalXerosis Cutis
Hoth Therapeutics, Inc.152 enrolled12 locationsNCT05639933
Recruiting
Phase 2
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
Autism Spectrum Disorder
New York State Psychiatric Institute30 enrolled2 locationsNCT05999240
Recruiting
Phase 2
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
Self-Injurychallenging behaviourAutism Spectrum Disorder+2 more
Jeremy Veenstra-vanderweele60 enrolled2 locationsNCT07091279
Recruiting
Phase 2
Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults
AnxietyAutism Spectrum Disorder
Southwest Autism Research & Resource Center108 enrolled1 locationNCT06526208
Recruiting
Phase 2
Trial of Diphenhydramine for Sleep in Children With Autism
AutismAutism Spectrum Disorder
Stanford University26 enrolled1 locationNCT05501678
Recruiting
Phase 2
Trial of Zolpidem for Sleep in Children With Autism
AutismAutism Spectrum Disorder
Stanford University26 enrolled1 locationNCT05540574
Recruiting
Phase 2
Trial of Suvorexant for Sleep in Children With Autism
AutismAutism Spectrum Disorder
Stanford University26 enrolled1 locationNCT05546554
Recruiting
Phase 1Phase 2
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
HealthyGastrointestinal DiseasesAutism Spectrum Disorder
Chang Gung Memorial Hospital60 enrolled1 locationNCT06290258
Recruiting
Phase 2Phase 3
Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders
AutismAutism Spectrum Disorder (ASD)Autism Disorder
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta90 enrolled2 locationsNCT07450443
Recruiting
Phase 2
Oxytocin Effects on Bone in Children With Autism Spectrum Disorder
Autism Spectrum DisorderBone Health
Elizabeth Austen Lawson96 enrolled2 locationsNCT05754073
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Muscular DystrophyLimb Girdle Muscular DystrophyLGMD2I+6 more
AskBio Inc10 enrolled6 locationsNCT05230459
Recruiting
Phase 2
Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma
SintilimabCentral Nervous System LymphomaPirtobrutinib
Zhejiang Cancer Hospital24 enrolled1 locationNCT07416890